Stock Alerts
April 25, 2024 | Daily JAM, GOOG, Long Term, Mid Term, Stock Alerts, Top 50 Stocks |
After the close today, Alphabet (GOOG) reported revenue of $80.5 billion, easily beating the consensus projection of $78.7 billion. Earning per share came in at $1.89 versus expectations for $1.50 a share. And none of the worries before the news turned out to be problems. Advertising revenue rose 13% to $61.7 billion. Ad revenue for YouTube–an area of worry rose 21% to $8.09 billion. Subscriptions, platforms and devices revenue jumped 18%.
April 24, 2024 | Daily JAM, Dividend Income, Jubak Picks, Long Term, Stock Alerts, Top 50 Stocks, V |
Tuesday, April 23, after the market close Visa (V) reported adjusted net income of $2.51 a share. That ws 7 cent a share more than the consensus of estimates from Wall Street analysts. Earnings rose 7% year-over-year in the quarter. Revenue climbed 10% from a year prior to $8.8 billion, also exceeding Wall Street estimates
April 23, 2024 | Daily JAM, Jubak Picks, Long Term, Millennial, Stock Alerts, Volatility |
I certainly understand the sell off in shares of development stage lithium producer Lithium Americas (LAC). Today, April 23, the stock closed at $4.68 a share, down another 1.47%. On April 16 the stock closed at $6.49 after hitting $7.34 on April 11. The culprit? The company closed a previously announced stock offer to 55 million shares at a price of $5 a share to raise $275 million.
You can see the problem, right? Stock is trading at $7.34 or $6.49 and then a big public offer dumps 55 million shares on the market at $5 a share. Ouch!! So I understand the price plunge–36.2% from April 11 to the close on April 23. And as someone who owns shares in his personal portfolio, I can’t say I’m a happy camper. But I will be being more in my personal account three days after this is posted.
March 26, 2024 | Daily JAM, Dividend Income, Special Reports, Stock Alerts |
Bookkeeping. I made Nike Pick No. 3 in my Special Report A New World for Dividend Investors. You can find the pick and write up i nmy long Special Report post. But I wanted to flag the pick here so no one would miss it. Dividend Pick #3: Nike (NKE)
March 26, 2024 | Daily JAM, Jubak Picks, LLY, Mid Term, Morning Briefing, NVO, Stock Alerts, VKTX |
First, it was Viking Therapeutics (VKTX) on the attack with trial results that shows its GLP-1 dibetes/weight loss drug out performing current leader of the pack drugs fro Novo Nordisk (NVO) and Eli Lilly (LLY). On the news Viking soared.
Then Novo Nordisk struct back with data of its own showing progress on an oral formulation of its rugs. (All existing GLP-1 drugs are delivered by injection.) That cratered Viking Shares. Now, March 26, Viking has released new Phase 1 trial data from a multiple ascending dose study of the oral version of VK2735, a dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors.
March 26, 2024 | Daily JAM, Stock Alerts, Top 50 Stocks |
Today’s Hot Button Moves NOW video is Buy Chipotle Mexican Grill (CMG). Chipotle announced it will  be spitting 50 to 1. With the stock , currently trading at $2800 the split will bring in a new group of investors. The stock popped about 3.5% the day following the announcement and continued to go up in the following days. It’s contrary to modern capital market theory that a stock announcing a split should go up, but it does need happen. Chipotle has a great long term story. It not only survived the COVID pandemic, but the company drove its digital loyalty membership up to 36 million people and added digital drive-thru lanes, leading to extraordinary growth. Chipotle had a 38% increase in earnings in 2023 and an 8% increase in comparable store sales. That, along with a 26% operating margin, continues to make Chipotle one o the most compelling consumer stocks to own,. I think owning this before the split, which will likely be approved in June, will get you appreciation from the pop on the split, as well as long term gains from this well-run company.  Tomorrow I’ll be adding these shares to my lot-term 50 Stocks Portfolio.
March 20, 2024 | Daily JAM, Jubak Picks, Mid Term, Stock Alerts |
Today’s Hot Button Moves NOW video is Buy Madrigal Pharmaceuticals (MDGL). This biotech company just received U.S. Food and Drug Administration approval for the first drug available for treating MASH (formerly known as NASH). MASH is a liver disease where fat builds up and compromise liver function. It’s measured in stages (1-4) and at stage 4, you need a liver transplant. Companies have long worked toward a treatment for the disease but have failed in trials or in getting FDA approval. The major achievements for Madrigal are efficacy in stopping the disease from progressing to the next stage and a clean label and no “black box warnings.” Additionally, this drug does not require a liver biopsy before a doctor can prescribe it and will be available after a much less invasive test. The market for this drug is forecast at $5 billion a year market. Madrigal will be able to start selling this drug in April. The Medical Technology Stock Letter, my preferred source on all things biotech, suggests buying MDGL below $300 with a target price of $400. I’m adding Madrigal Pharmaceuticals to my 12-18 month Jubak’s Picks Portfolio.
March 12, 2024 | Daily JAM, Jubak Picks, QCOM, Stock Alerts, Videos |
Today’s Quick Pick is Qualcomm, (QCOM). I always look for product momentum in technology stocks, and Qualcomm’s pipeline is very promising. The company reported a good first quarter for 2024 but I’m focused on growth for their Snapdragon chip which is used in cell phones, cars, and the internet of things. Qualcomm has recently renewed its chip agreements with Apple and Samsung. Samsung’s Galaxy 24 is the first cell phone to include AI technology powered by Snapdragon and sales are up 13% year over year from 2023 and 47% from 2024. It’s likely more companies will be looking to add AI to their phones and I think Qualcomm has a leading position in that market. A new Snapdragon product, X-Elite, will put AI on PCs and is coming out this year. In 2023 the Snapdragon chip was also installed in infotainment modules for 75 new car models and the company’s automotive revenue is up about 12% this quarter. The Internet of Things is growing more slowly but is still growing. Morningstar says the stock is trading at a 22% premium, but I find that to be very, very conservative. While this stock isn’t a bargain at the moment this is a decent time to get in on an AI stock with promising pipeline momentum, and I don’t see it being more reasonable any time soon. I added Qualcomm to my Jubak’s Picks Portfolio on January 15, 2024. The position is up 23.5% since then as of the close on March 12.
March 7, 2024 | Daily JAM, Mid Term, Morning Briefing, Stock Alerts |
Right now Tesla (TSLA) is a case study in how sentiment on a stock changes, how long it takes sentiment to change (and recover), and the stages of sentiment change. You understanding of this process should be our guide to whether you want to own Tesla and when. Tesla (TSLA) could potentially lose money in 2024, Morgan Stanley’s Adam Jonas wrote in a note to investors this week. And he cut his Tesla earnings projections by 25% to $1.51 a share from a prior $2.04. Gross profit margins will fall to 11.4% (excluding regulatory credits that Tesla gets paid by automakers looking to meet EPA mileage and emissions rules.) And this is from a Tesla bull.
March 6, 2024 | AAPL, Daily JAM, Stock Alerts, Top 50 Stocks |
Apple (AAPL) shares are down 12% for 2024 to date as of March 5. But I don’t think Apple’s troubles are over. And it will take some pretty fast taking at the June WWDC (World Wide Developers Conference) to reverse the downtrend in the shares. Absent a knock-it-out-of-the-park performance from CEO Tim Cook, I think the weakness will continue the company’s product announcements in September. And maybe longer. Those of you who have long memories may recall that I sold my shares of Apple in my 12-18 month Jubak’s Picks Portfolio back on September 12, 2023 at $176.30 a share. (I kept my long-term position in Apple in my 50 Stock Portfolio.) That sell turned out to be early. Painfully early. The stock hit a 2023 high of $198 on December 14. And it has only recently moved below my September sell, closing at $169.62 on March 6. But the iPhone China problem that led to that sell call has gotten worse. And since then Apple has developed an AI problem as well. And unfortunately the China problem and the AI problem mix to form an especially potent negative brew.
February 28, 2024 | Daily JAM, Jubak Picks, LLY, Stock Alerts, Volatility |
Yesterday, February 28, development-stage biotech Viking Therapeutics (VKTX) announced results from a Phase 2 training of its GLP-1 weight-loss drug candidate that that showed the potential for the VK2735 compound two move to be best in class in the $36.5 billion (revenue) market for GLP diabetes-control and weight-loss drugs. I will add Viking Therapeutic to my Volatility Portfolio and to my Jubak’s Picks Portfolio today, February 29, with a target price of $150.
February 21, 2024 | Daily JAM, Long Term, NVDA, Stock Alerts, Top 50 Stocks |
Well, optimistic analysts just weren’t optimistic enough about Nvidia’s (NVDA) fourth quarter 2023 earnings. The company reported adjusted earnings of $5.16 per share on revenue of $22.1 billion. Analysts were expecting earnings of $4.60 a share and revenue of $20.4 billion.
